Popular on Rezul
- Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
- ClearLead Digital Named an "Emerging Leader" in Independent 2026 Property Management Website & SEO Report
- Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
- AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
- The Importance of Community Connections
- New Luxury Single Family Homes From $976,990 in Manalapan
- Heritage at South Brunswick Unveils Luxury Resort-Style Amenities Designed for Every Generation
- CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
- Industrial and systems engineers celebrate key leaders in the field at IISE Annual Conference
- Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
Similar on Rezul
- Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
- Salt Lake City Families Turn to Private Autopsy Services for Faster Answers After Unexpected Loss
- $20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
- HomeCentris Home Health Achieves 5-Star CMS Rating
- HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
- CGI Announces Pre-Order Launch for New Integrated Behavioral Health Book
- Healthi Life, Bangkok's Urban Longevity House, Honoured at Asia-Pacific Awards 2025
- Psychiatric Hospitals Fail to Warn Electroshock Patients of FDA-Cited Risks in Estimated $7 Billion Industry
KidneyKind Marks America's 250th Birthday with $25 First-Year Promo on Kidney Health App
Rezul News/10739017
Patient-built iOS app for dialysis tracking offers limited-time annual discount through July 14
PORT ST. LUCIE, Fla. - Rezul -- KindSoft LLC announced today that KidneyKind, the patient-built kidney health tracking app for iPhone and Apple Watch, is offering its annual subscription for $25 for the first year — a 61 percent discount from the regular $64.99 — in honor of the United States' 250th birthday. The promotion runs through July 14, 2026, and is available in the United States, Canada, United Kingdom, Ireland, Australia, and Japan.
The discount is redeemable through the App Store using offer code USA250. The promotion is available to new subscribers, existing subscribers, and users who previously tried the app — making it an accessible re-entry point for patients who downloaded KidneyKind during a difficult period and did not continue.
"Five years ago I started peritoneal dialysis. Two years ago I started building the app I needed to manage it," said Mike McGarry, founder of KindSoft LLC and a kidney patient himself. "Kidney disease management should not require six different apps. KidneyKind exists because I built what I could not find."
More on Rezul News
KidneyKind tracks all four major dialysis modalities — peritoneal exchange, peritoneal cycler, home hemodialysis, and in-center hemodialysis — along with daily vitals, medications, lab results including kidney-specific markers like Kt/V and eGFR, and the kidney transplant journey from referral through listing. The app is available on iPhone, Apple Watch, and iPad, with watch complications and a Home Screen widget for at-a-glance fluid limit tracking. All patient data is stored in the user's private iCloud account; KindSoft operates no servers and collects no analytics.
The app launched in the United States in April 2026 and expanded to five additional territories over the following months, with full Japanese translation shipping in May 2026.
Patients can redeem the promotion at:
https://apps.apple.com/redeem?ctx=offercodes&id=6761937176&code=USA250
The subscription renews at the regular $64.99 per year after the first year and can be cancelled at any time through iPhone Settings.
More on Rezul News
For more information, visit https://kidneykindapp.com.
ABOUT KIDNEYKIND
KidneyKind is a privacy-first kidney health and dialysis tracking app for iPhone, Apple Watch, and iPad, built by a peritoneal dialysis patient. Available in six countries with full English and Japanese language support, KidneyKind tracks dialysis sessions, daily vitals, lab results, medications, and the kidney transplant journey from referral through listing. Patient data is stored exclusively in the user's private iCloud account.
ABOUT KINDSOFT LLC
KindSoft LLC is an independent healthcare software company founded in 2026 by Mike McGarry, who lives with polycystic kidney disease and is on peritoneal dialysis. KindSoft builds technology with kindness — patient-focused apps that prioritize privacy, dignity, and daily usability for people managing chronic conditions.
The discount is redeemable through the App Store using offer code USA250. The promotion is available to new subscribers, existing subscribers, and users who previously tried the app — making it an accessible re-entry point for patients who downloaded KidneyKind during a difficult period and did not continue.
"Five years ago I started peritoneal dialysis. Two years ago I started building the app I needed to manage it," said Mike McGarry, founder of KindSoft LLC and a kidney patient himself. "Kidney disease management should not require six different apps. KidneyKind exists because I built what I could not find."
More on Rezul News
- Arizona Christian Homeschools Launches Statewide Directory
- Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It
- Senco Home Services Expands Residential Construction Services
- Ricci's Painting & Contracting Expands Home Transformation Services
- Derek Cook's Roofing Helps New England Homeowners
KidneyKind tracks all four major dialysis modalities — peritoneal exchange, peritoneal cycler, home hemodialysis, and in-center hemodialysis — along with daily vitals, medications, lab results including kidney-specific markers like Kt/V and eGFR, and the kidney transplant journey from referral through listing. The app is available on iPhone, Apple Watch, and iPad, with watch complications and a Home Screen widget for at-a-glance fluid limit tracking. All patient data is stored in the user's private iCloud account; KindSoft operates no servers and collects no analytics.
The app launched in the United States in April 2026 and expanded to five additional territories over the following months, with full Japanese translation shipping in May 2026.
Patients can redeem the promotion at:
https://apps.apple.com/redeem?ctx=offercodes&id=6761937176&code=USA250
The subscription renews at the regular $64.99 per year after the first year and can be cancelled at any time through iPhone Settings.
More on Rezul News
- PRM Capital Expands 100% Financing Rehab Loan Program for Cincinnati, Ohio Real Estate Investors
- PRM Capital Launches 100% Financing Rehab Loan Program for Missouri Real Estate Investors
- Alvear Homes Expands 2026 Buyer Education Initiative to Help North Carolina Homebuyers
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- Boston Industrial Solutions Introduces High-Performance Primer for Bonding Liquid Silicone to Epoxy
For more information, visit https://kidneykindapp.com.
ABOUT KIDNEYKIND
KidneyKind is a privacy-first kidney health and dialysis tracking app for iPhone, Apple Watch, and iPad, built by a peritoneal dialysis patient. Available in six countries with full English and Japanese language support, KidneyKind tracks dialysis sessions, daily vitals, lab results, medications, and the kidney transplant journey from referral through listing. Patient data is stored exclusively in the user's private iCloud account.
ABOUT KINDSOFT LLC
KindSoft LLC is an independent healthcare software company founded in 2026 by Mike McGarry, who lives with polycystic kidney disease and is on peritoneal dialysis. KindSoft builds technology with kindness — patient-focused apps that prioritize privacy, dignity, and daily usability for people managing chronic conditions.
Source: KindSoft LLC
0 Comments
Latest on Rezul News
- Leicester UK Manufacturer Tabletop Tyrant Secures Flawless 100% Customer Satisfaction Rating Across 5,800+ Orders
- The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth
- Cre8ive Realty Brings Nearly Three Decades of Real Estate Expertise to Soutwest Florida
- Mesa West Capital Originates $82.5 Million Loan to Refi Seattle Apartment Community
- Your Mortgage Toolbox Announces Branded Mortgage Calculators for Real Estate Agents and Mortgage Lenders
- Cango Mobility x Hikvision Announce Strategic Partnership
- HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
- Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
- Century Fasteners de Mexico Exhibiting at 2026 Farnborough International Airshow
- George Martinez Completes Community Re-distribution Initiative, Returning $5,000 In Campaign Resources To Anchorage Nonprofits
- Manova Partners Moves into Nashville Industrial Market with Purchase of Fully Leased Gateway 65
- Turnleaf welcomes M/I Homes to Premier Builder Team
- Mister Omaha Tries The Turf At Lone Star Park
- Andrew D. Levine Releases The Lily Network, an Indian Noir Mystery of Power, Paperwork & Murder
- The Mapping Software Behind America's Viral Maps Just Got Faster and Smarter
- Republican National Hispanic Assembly Of FL Stands Firmly In Favor Of The Property Tax Relief
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
- Joulescope JS320 Launches to Help Engineers Develop Battery-Powered Devices with Greater Confidence
- Ghanaian Afrobeat Artist Praise Kusi Announces Upcoming EP "After 21:00" Releasing July 3, 2026
- TURRENTINE: A Family Legacy United Through Music